Test Price
140 AED✅ Home Collection Available
Rubella (German Measles) Antibodies Panel, IgG & IgM in UAE | 140 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- ✓ 99.9% Diagnostic Sensitivity – ISO 9001:2015 accredited laboratory employing Chemiluminescent Immunoassay (CLIA) for precise serological detection of rubella-specific IgG and IgM antibodies.
- ✓ VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM. Hospital-grade sample transport ensures specimen integrity for serum-based testing.
- ✓ Telephonic Post-Test Clinical Guidance – DHA-licensed physician interpretation of your IgG/IgM panel results with actionable recommendations.
- ✓ Direct Insurance Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Rubella (German Measles) Antibodies Panel quantitatively measures IgG and IgM antibodies against rubella virus in human serum. This panel serves three essential clinical purposes: confirming immunity prior to pregnancy, diagnosing acute rubella infection, and evaluating post-vaccination seroconversion. The test requires no special preparation and is suitable for adults, adolescents, and children.
Our laboratory employs the Chemiluminescent Immunoassay (CLIA) platform, which offers superior analytical sensitivity and specificity compared to conventional ELISA methods. The assay utilizes paramagnetic microparticles coated with rubella virus antigens to capture specific antibodies, followed by chemiluminescent detection. This methodology provides same-day results with minimal cross-reactivity from other viral antibodies.
| Feature | Our CLIA Panel (ISO 9001:2015) | Standard ELISA Alternative |
|---|---|---|
| Methodology | Chemiluminescent Immunoassay (CLIA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Analytical Sensitivity | 99.9% with low cross-reactivity | 95–98% |
| Turnaround Time | Same day (under 8 hours for samples collected by 11 AM) | 2–3 business days |
| Accreditation | ISO 9001:2015 & DHA-compliant | Variable |
Physician Insight & Safety Protocols
Rubella IgG and IgM results require careful clinical correlation with the patient's vaccination history, pregnancy status, and exposure timeline. An isolated positive IgM in an asymptomatic pregnant patient may represent a false positive or recent vaccination rather than acute infection. Confirmatory avidity testing or repeat serology after 2–3 weeks is recommended. For women planning conception, an IgG-negative result indicates susceptibility and MMR vaccination is advised with a 4-week pregnancy delay. Dr. Ajay Singh, General Practitioner, DHA License 36234132, emphasizes: "Timely rubella serology in early pregnancy is essential to identify susceptible women and prevent congenital rubella syndrome, which carries devastating fetal consequences."
Medication & Treatment Advisory
Do not discontinue, alter, or initiate any prescribed medication or supplement based solely on rubella antibody test results. All clinical decisions, including MMR vaccination during the postpartum period or immunoglobulin therapy following exposure, must be made by your treating physician after comprehensive clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Known severe bleeding disorder (e.g., unmanaged hemophilia) – venipuncture may pose additional risk; consult hematologist prior to blood draw.
- Inability to obtain a peripheral venous sample due to inaccessible veins or patient refusal.
- Seek immediate emergency medical care if you experience: high fever exceeding 39°C, severe joint pain or swelling, widespread purpuric or petechial rash, or if you are pregnant and have had known exposure to a person with confirmed rubella infection.
Patient FAQ & Clinical Guidance
1. What does a positive Rubella IgG result indicate?
A positive Rubella IgG result confirms past infection or vaccination, indicating protective immunity against rubella virus. For women planning pregnancy, this is a reassuring finding that eliminates the need for MMR vaccination prior to conception. However, IgG levels should be interpreted alongside IgM results and clinical history. Your physician may recommend a quantitative IgG titre to confirm adequate antibody levels.
2. Is the Rubella antibody blood test safe during pregnancy?
Yes, this test is completely safe during all trimesters of pregnancy. It involves a standard venipuncture blood draw requiring no fasting, contrast agents, or radiation exposure. Rubella immunity screening is a routine prenatal investigation recommended by DHA guidelines to identify seronegative women who may require postpartum vaccination. No special preparation is needed, and you may continue all prescribed prenatal vitamins and medications.
3. When will I receive my Rubella IgG and IgM results?
Results are reported on the same day of sample collection, with a turnaround time of under 8 hours for specimens received in the laboratory by 11 AM. Our daily CLIA processing enables rapid IgG and IgM quantification, facilitating timely clinical decisions. You will receive a secure, digitally signed PDF report via WhatsApp or email, and our physicians are available for telephonic result interpretation upon request.
UAE Regulatory & Data Privacy Adherence
Data Protection. DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), ensuring that all patient health information is collected, processed, and stored with the highest standards of confidentiality and security.
Health Information Governance. Our laboratory information management systems adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, guaranteeing the integrity and security of electronic health records and diagnostic data.
Clinical Safety & Consent. All diagnostic procedures, including venipuncture and serological testing, follow the clinical safety standards outlined in Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed patient consent and adherence to best medical practices.
Clinical & Logistical Metadata
| Test Name | Rubella (German Measles) Antibodies Panel, IgG & IgM |
| Price (AED) | 140 AED |
| Turnaround Time | Same day (under 8 hours for samples collected by 11 AM) |
| Sample Type / Matrix | Serum (2 mL in SST, minimum 1 mL) via standard venipuncture |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) |
| ICD-10-CM Code | Z01.84 |
| LOINC Code | 40666-6 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians